Baker Bros. Advisors’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$106M	Buy	30,275,938 +2,750,298	+10%	+$9.9M	0.61%	24
2025 Q4	$94.1M	Hold	27,525,640	–	–	0.55%	27
2025 Q3	$138M	Hold	27,525,640	–	–	1%	13
2025 Q2	$94.4M	Hold	27,525,640	–	–	0.92%	14
2025 Q1	$61.4M	Hold	27,525,640	–	–	0.68%	18
2024 Q4	$80.7M	Hold	27,525,640	–	–	0.86%	17
2024 Q3	$71.6M	Hold	27,525,640	–	–	0.74%	20
2024 Q2	$81.5M	Hold	27,525,640	–	–	1.04%	16
2024 Q1	$125M	Buy	27,525,640 +4,615,887	+20%	+$23.6M	1.56%	8
2023 Q4	$131M	Buy	22,909,753 +2,146,430	+10%	+$9.95M	1.49%	11
2023 Q3	$95.5M	Buy	20,763,323 +4,313,143	+26%	+$26.2M	0.55%	12
2023 Q2	$106M	Buy	16,450,180 +6,000,000	+57%	+$40.9M	0.62%	14
2023 Q1	$78.8M	Hold	10,450,180	–	–	0.43%	15
2022 Q4	$106M	Hold	10,450,180	–	–	0.64%	16
2022 Q3	$103M	Hold	10,450,180	–	–	0.68%	12
2022 Q2	$111M	Hold	10,450,180	–	–	0.63%	11
2022 Q1	$102M	Hold	10,450,180	–	–	0.59%	13
2021 Q4	$149M	Hold	10,450,180	–	–	0.73%	13
2021 Q3	$209M	Hold	10,450,180	–	–	0.92%	12
2021 Q2	$230M	Hold	10,450,180	–	–	1.01%	12
2021 Q1	$355M	Hold	10,450,180	–	–	1.54%	11
2020 Q4	$421M	Buy	+10,450,180	New	+$478M	1.58%	11